GATA4 and GATA6 silencing in ovarian granulosa cells affects levels of mRNAs involved in steroidogenesis, extracellular structure organization, IGF-I activity, and apoptosis

Endocrinology

Volumn 154, Issue 12, 2013, Pages 4845-4858

  Bennett, Jill ^a   Baumgarten, Sarah C ^a   Stocco, Carlos ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; FOLLITROPIN RECEPTOR; GONADOTROPIN; GROWTH FACTOR; INHIBIN A; INHIBIN B; LUTEINIZING HORMONE RECEPTOR; MESSENGER RNA; PREGNANCY ASSOCIATED PLASMA PROTEIN A; SOMATOMEDIN C; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 6; VERSICAN; FOLLITROPIN; GATA4 PROTEIN, MOUSE; GATA6 PROTEIN, MOUSE; SOMATOMEDIN BINDING PROTEIN; STEROID; TRANSCRIPTOME;

ANIMAL CELL; APOPTOSIS; ARTICLE; BIOASSAY; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; GRANULOSA CELL; HORSE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OVARY FUNCTION; OVULATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCTION; SIGNAL TRANSDUCTION; STEROIDOGENESIS; SUBFERTILITY; ANIMAL; GENE SILENCING; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; PREGNANCY;

ANIMALS; APOPTOSIS; FEMALE; FOLLICLE STIMULATING HORMONE; GATA4 TRANSCRIPTION FACTOR; GATA6 TRANSCRIPTION FACTOR; GENE SILENCING; GRANULOSA CELLS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, KNOCKOUT; PREGNANCY; RNA, MESSENGER; SIGNAL TRANSDUCTION; STEROIDS; TRANSCRIPTOME;

EID: 84888267929     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1410     Document Type: Article

References (68)

1. Bennett J, Wu YG, Gossen J, Zhou P, Stocco C. Loss of GATA-6 and GATA-4 in granulosa cells blocks folliculogenesis, ovulation, and follicle stimulating hormone receptor expression leading to female infertility. Endocrinology. 2012;153:2474-2485.
2. Laitinen MP, Anttonen M, Ketola I, et al. Transcription factors GATA-4 and GATA-6 and a GATA family cofactor, FOG-2, are expressed in human ovary and sex cord-derived ovarian tumors. J Clin Endocrinol Metab. 2000;85:3476-3483.
3. Gillio-Meina C, Hui YY, LaVoie HA. GATA-4 and GATA-6 transcription factors: expression, immunohistochemical localization, and possible function in the porcine ovary. Biol Reprod. 2003;68:412-422.
4. Lavoie HA, McCoy GL, Blake CA. Expression of the GATA-4 and GATA-6 transcription factors in the fetal rat gonad and in the ovary during postnatal development and pregnancy. Mol Cell Endocrinol. 2004;227:31-40.
5. Molkentin JD. The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem . 2000;275:38949 -38952.
6. Merika M, Orkin SH. DNA-binding specificity of GATA family transcription factors. Mol Cell Biol. 1993;13:3999-4010.
7. Kyrönlahti A, Vetter M, Euler R, et al. GATA4 deficiency impairs ovarian function in adult mice. Biol Reprod . 2011;84:1033-1044.
8. Kwintkiewicz J, Cai Z, Stocco C. Follicle-stimulating hormone-induced activation of Gata4 contributes in the up-regulation of Cyp19 expression in rat granulosa cells. Mol Endocrinol. 2007;21:933-947.
9. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 2001;98:5116-5121.
10. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545-15550.
11. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet . 2003;34:267-273.
12. Robert NM, Miyamoto Y, Taniguchi H, Viger RS. LRH-1/ NR5A2 cooperates with GATA factors to regulate inhibin α-subunit promoter activity. Mol Cell Endocrinol. 2006;257-258:65-74.
13. Anttonen M, Parviainen H, Kyrönlahti A, et al. GATA-4 is a granulosa cell factor employed in inhibin-α activation by the TGF-β pathway. J Mol Endocrinol. 2006;36:557-568.
14. Mayo KE. Inhibin and activin molecular aspects of regulation and function. Trends Endocrinol Metab. 1994;5:407-415.
15. Knight PG, Satchell L, Glister C. Intra-ovarian roles of activins and inhibins. Mol Cell Endocrinol. 2012;359:53-65.
16. Salmon NA, Handyside AH, Joyce IM. Oocyte regulation of anti-Mullerian hormone expression in granulosa cells during ovarian follicle development in mice. Dev Biol. 2004;266:201-208.
17. Baarends WM, Uilenbroek JT, Kramer P, et al. Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribo-nucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology. 1995;136:4951-4962.
18. Weenen C, Laven JS, Von Bergh AR, et al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10:77-83.
19. Gruijters MJ, Visser JA, Durlinger AL, Themmen AP. Anti-Müllerian hormone and its role in ovarian function. Mol Cell Endocrinol. 2003;211:85-90.
20. Viger RS, Guittot SM, Anttonen M, Wilson DB, Heikinheimo M. Role of the GATA family of transcription factors in endocrine development, function, and disease. Mol Endocrinol. 2008;22:781-798.
21. Sudo S, Avsian-Kretchmer O, Wang LS, Hsueh AJ. Protein related to DAN and cerberus is a bone morphogenetic protein antagonist that participates in ovarian paracrine regulation. J BiolChem. 2004;279:23134-23141.
22. Pangas SA, Jorgez CJ, Matzuk MM. Growth differentiation factor 9 regulates expression of the bone morphogenetic protein antagonist gremlin. J Biol Chem. 2004;279:32281-32286.
23. Han EH, Kim HG, Hwang YP, Song GY, Jeong HG. Prostaglandin E2 induces CYP1B1 expression via ligand-independent activation of the ERα pathway in human breast cancer cells. Toxicol Sci. 2010;114:204-216.
24. Brown SA, Hay RV, Schreiber JR. Relationship between serum estrogen and level of apolipoprotein E in human ovarian follicular fluid. Fertil Steril. 1989;51:639-643.
25. Nicosia M, Moger WH, Dyer CA, Prack MM, Williams DL. Apo-lipoprotein- E messenger RNA in rat ovary is expressed in theca and interstitial cells and presumptive macrophage, but not in granulosa cells. Mol Endocrinol. 1992;6:978-988.
26. Shozu M, Minami N, Yokoyama H, et al. ADAMTS-1 is involved in normal follicular development, ovulatory process and organization of the medullary vascular network in the ovary. J Mol Endocrinol. 2005;35:343-355.
27. Brown HM, Dunning KR, Robker RL, et al. ADAMTS1 cleavage of versican mediates essential structural remodeling of the ovarian follicle and cumulus-oocyte matrix during ovulation in mice. Biol Reprod. 2010;83:549-557.
28. Russell DL, Ochsner SA, Hsieh M, Mulders S, Richards JS. Hor-mone-regulated expression and localization of versican in the rodent ovary. Endocrinology. 2003;144:1020-1031.
29. Doyle KM, Russell DL, Sriraman V, Richards JS. Coordinate transcription of the ADAMTS-1 gene by luteinizing hormone and progesterone receptor. Mol Endocrinol. 2004;18:2463-2478.
30. Zhou P, Baumgarten SC, Wu Y, et al. IGF-I signaling is essential for FSH stimulation of AKT and steroidogenic genes in granulosa cells. Mol Endocrinol. 2013;27:511-523.
31. Monget P, Monniaux D, Pisselet C, Durand P. Changes in insulin-like growth factor-I (IGF-I), IGF-II, and their binding proteins during growth and atresia of ovine ovarian follicles. Endocrinology. 1993;132:1438-1446.
32. Silva JR, Figueiredo JR, van den Hurk R. Involvement of growth hormone (GH) and insulin-like growth factor (IGF) system in ovarian folliculogenesis. Theriogenology. 2009;71:1193-1208.
33. Monget P, Fabre S, Mulsant P, et al. Regulation of ovarian follicu-logenesis by IGF and BMP system in domestic animals. Domest Anim Endocrinol. 2002;23:139-154.
34. Rees C, Clemmons DR, Horvitz GD, Clarke JB, Busby WH. A pro-tease-resistant form of insulin-like growth factor (IGF) binding protein 4 inhibits IGF-1 actions. Endocrinology. 1998;139:4182-4188.
35. Funston RN, Seidel GE Jr, Klindt J, Roberts AJ. Insulin-like growth factor I and insulin-like growth factor-binding proteins in bovine serum and follicular fluid before and after the preovulatory surge of luteinizing hormone. Biol Reprod. 1996;55:1390-1396.
36. Adashi EY, Resnick CE, Hernandez ER, Hurwitz A, Rosenfeld RG. Follicle-stimulating hormone inhibits the constitutive release of in-sulin-like growth factor binding proteins by cultured rat ovarian granulosa cells. Endocrinology. 1990;126:1305-1307.
37. Iwashita M, Kudo Y, Yoshimura Y, Adachi T, Katayama E, Takeda Y. Physiological role of insulin-like-growth-factor-binding protein-4 in human folliculogenesis. Horm Res. 1996;46(suppl 1):31-36.
38. Echternkamp SE, Howard HJ, Roberts AJ, Grizzle J, Wise T. Relationships among concentrations of steroids, insulin-like growth factor-I, and insulin-like growth factor binding proteins in ovarian follicular fluid of beef cattle. Biol Reprod. 1994;51:971-981.
39. Salih DA, Tripathi G, Holding C, et al. Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice. Proc Natl Acad Sci USA. 2004;101:4314-4319.
40. Wright RJ, Holly JM, Galea R, Brincat M, Mason HD. Insulin-like growth factor (IGF)-independent effects of IGF binding protein-4 on human granulosa cell steroidogenesis. Biol Reprod. 2002;67:776-781.
41. Mazerbourg S, Overgaard MT, Oxvig C, et al. Pregnancy-associated plasma protein-A (PAPP-A) in ovine, bovine, porcine, and equine ovarian follicles: involvement in IGF binding protein-4 proteolytic degradation and mRNA expression during follicular development. Endocrinology. 2001;142:5243-5253.
42. Hourvitz A, Kuwahara A, Hennebold JD, et al. The regulated expression of the pregnancy-associated plasma protein-A in the rodent ovary: a proposed role in the development of dominant follicles and of corpora lutea. Endocrinology . 2002;143:1833-1844.
43. Nyegaard M, Overgaard MT, Su YQ, et al. Lack of functional preg-nancy-associated plasma protein-A (PAPPA) compromises mouse ovarian steroidogenesis and female fertility. Biol Reprod. 2010;82:1129-1138.
44. Rivera GM, Fortune JE. Proteolysis of insulin-like growth factor binding proteins -4 and -5 in bovine follicular fluid: implications for ovarian follicular selection and dominance. Endocrinology. 2003;144:2977-2987.
45. He X, Zhu Z, Johnson C, et al. PIK3IP1, a negative regulator of PI3K, suppresses the development of hepatocellular carcinoma. Cancer Res. 2008;68:5591-5598.
46. Nakashima T, Sekiguchi T, Kuraoka A, et al. Molecular cloning of a human cDNA encoding a novel protein, DAD1, whose defect causes apoptotic cell death in hamster BHK21 cells. Mol Cell Biol. 1993;13:6367-6374.
47. Sacilotto N, Espert A, Castillo J, Franco L, Lopez-Rodas G. Epigenetic transcriptional regulation of the growth arrest-specific gene 1 (Gas1) in hepatic cell proliferation at mononucleosomal resolution. PLoS One. 2011;6:e23318.
48. Hutchison MR, Bassett MH, White PC. SCF, BDNF, and Gas6 are regulators of growth plate chondrocyte proliferation and differentiation. Mol Endocrinol. 2010;24:193-203.
49. Peterson TR, Laplante M, Thoreen CC, et al. DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell. 2009;137:873-886.
50. Schmelzle T, Hall MN. TOR, a central controller of cell growth. Cell. 2000;103:253-262.
51. Thomas G, Hall MN. TOR signalling and control of cell growth. Curr Opin Cell Biol. 1997;9:782-787.
52. Trapasso F, Aqeilan RI, Iuliano R, et al. Targeted disruption of the murine homeodomain-interacting protein kinase-2 causes growth deficiency in vivo and cell cycle arrest in vitro. DNACell Biol. 2009;28:161-167.
53. Brandon EP, Idzerda RL, McKnight GS. PKAisoforms, neural pathways, and behaviour: making the connection. Curr Opin Neurobiol. 1997;7:397-403.
54. Carr DW, Cutler RE Jr, Cottom JE, et al. Identification of cAMP-dependent protein kinase holoenzymes in preantral- and preovula-tory-follicle-enriched ovaries, and their association with A-kinase-anchoring proteins. Biochem J. 1999;344(pt 2):613-623.
55. Fitzpatrick SL, Richards JS. Regulation of cytochrome P450 aro-matase messenger ribonucleic acid and activity by steroids and go-nadotropins in rat granulosa cells. Endocrinology. 1991;129:1452-1462.
56. Regev A, Goldman S, Shalev E. Expression of plexin-B1 in the mouse ovary and its possible role in follicular development. Fertil Steril. 2005;84(suppl 2):1210-1219.
57. Regev A, Goldman S, Shalev E. Semaphorin-4D (Sema-4D), the plexin-B1 ligand, is involved in mouse ovary follicular development. Reprod Biol Endocrinol. 2007;5:12.
58. Scott GA, McClelland LA, Fricke AF, Fender A. Plexin C1, a receptor for semaphorin 7a, inactivates cofilin and is a potential tumor suppressor for melanoma progression. J Invest Dermatol. 2009;129:954-963.
59. Messina A, Ferraris N, Wray S, et al. Dysregulation of semaphorin7A/β1-integrin signaling leads to defective GnRH-1 cell migration, abnormal gonadal development and altered fertility. Hum Mol Genet. 2011;20:4759-4774.
60. Karlsson AB, Maizels ET, Flynn MP, et al. Luteinizing hormone receptor-stimulated progesterone production by preovulatory granulosa cells requires protein kinase A-dependent activation/dephos-phorylation of the actin dynamizing protein cofilin. Mol Endocrinol. 2010;24:1765-1781.
61. Fan HY, Liu Z, Shimada M, et al. MAPK3/1 (ERK1/2) in ovarian granulosa cells are essential for female fertility. Science. 2009;324:938-941.
62. Olson MF, Marais R. Ras protein signalling. Semin Immunol. 2000;12:63-73.
63. Rodgers RJ, Irving-Rodgers HF. Formation of the ovarian follicular antrum and follicular fluid. Biol Reprod. 2010;82:1021-1029.
64. Rahmani M, Wong BW, Ang L, et al. Versican: signaling to transcriptional control pathways. Can J Physiol Pharmacol. 2006;84:77-92.
65. Zimmermann DR, Dours-Zimmermann MT. Extracellular matrix of the central nervous system: from neglect to challenge. Histochem Cell Biol. 2008;130:635-653.
66. Kumar TR, Wang Y, Lu N, Matzuk MM. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet. 1997;15:201-204.
67. Dierich A, Sairam MR, Monaco L, et al. Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal im-balance. Proc Natl Acad Sci USA. 1998;95:13612-13617.
68. Baker J, Hardy MP, Zhou J, et al. Effects of an Igf1 gene null mutation on mouse reproduction. Mol Endocrinol. 1996;10:903-918.